We are live on ! Find out more
FC

Francis Chou Chou Associates Management

AUM $217M
1-Year Est. Return 23.58%
 

Francis Chou is the founder of Chou Associates Management and a Canadian value investor known for deep-value and special-situation securities. His funds have historically owned a mix of equities and distressed or complex instruments when prices offered a margin of safety. Chou’s annual reports are read for candid discussion of mistakes, opportunities, and long-term results.

This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+23.58%
3 Year Est. Return
+66.36%
5 Year Est. Return
+125.96%
10 Year Est. Return
+766.48%
AUM
$301M
AUM Growth
-$11.3M
Cap. Flow
-$11.8M
Cap. Flow %
-3.93%
Top 10 Hldgs %
76.26%
Holding
29
New
2
Increased
2
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$11.8M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.34M
3
BHC icon
Bausch Health
BHC
+$5.41M
4
SD icon
SandRidge Energy
SD
+$2.15M

Top Sells

Rank Stock Value
1
JPM.WS
JPMorgan Chase
JPM.WS
+$23.3M
2
NOK icon
Nokia
NOK
+$5.03M
3
BAC.WS.A
Bank Of America Corporation Ws A
BAC.WS.A
+$3.44M
4
AZN icon
AstraZeneca
AZN
+$711K
5
GSK icon
GSK
GSK
+$347K

Sector Composition

Rank Sector Weight
1 Financials 29.32%
2 Healthcare 20.58%
3 Consumer Discretionary 10.15%
4 Materials 9.42%
5 Technology 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
26
AstraZeneca
AZN
$257B
– –
-6,500
Closed -$711K
GSK icon
27
GSK
GSK
$105B
– –
-14,400
Closed -$347K
1
2

Similar funds

FF
Friedenthal Financial Marlton, New Jersey $217M AUM 21.15% 1-Year Est. Return
BRPW
Ballast Rock Private Wealth Charleston, South Carolina $217M AUM
TGM
Tenzing Global Management San Francisco, California $216M AUM 75.21% 1-Year Est. Return
BAM
Bellevue Asset Management Bellevue, Washington $217M AUM 14.36% 1-Year Est. Return
O3W
Omni 360 Wealth Plainsboro, New Jersey $216M AUM 19.47% 1-Year Est. Return
EG
Enstar Group Hamilton, Bermuda $216M AUM 13.01% 1-Year Est. Return
GAA
Guardian Asset Advisors Mechanicsburg, Pennsylvania $217M AUM 27.27% 1-Year Est. Return
ICM
Islay Capital Management Lubbock, Texas $216M AUM 20.41% 1-Year Est. Return

Francis Chou's Q1 2017 Portfolio in Review

As of Q1 2017, Francis Chou held 29 positions worth $301M, down 3.6% from $313M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Francis Chou withdrew a net $11.8M in Q1 2017, closing 2 positions and reducing 3 holdings. Its most notable exit was AstraZeneca, an estimated $711K position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Francis Chou opened a new position in Endo International plc worth $10.6M.

  • Francis Chou's largest Q1 2017 buy was Endo International plc: 950,000 shares worth $10.6M.
  • Francis Chou added most to Bausch Health in Q1 2017, an estimated $5.41M increase.
  • Francis Chou's biggest Q1 2017 reduction was JPMorgan Chase, cutting an estimated $23.3M.
  • Francis Chou fully exited AstraZeneca in Q1 2017, selling an estimated $711K.
  • Francis Chou's ten largest holdings make up 76% of its $301M portfolio in Q1 2017.
  • Francis Chou opened 2 new positions and closed 2 in Q1 2017.
  • Francis Chou's portfolio value fell 3.6% quarter-over-quarter to $301M.

Based on Chou Associates Management's 13F filing for Q1 2017, filed 12 May 2017.